CHYUNG YUNG H.
SEC CIK 1740377 · EDGAR
Most active insiders at KROS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schneeberger Daniel | 10% | — | $95.66M |
| 2 | Pontifax (China) IV L.P. | 10% | — | $84.98M |
| 3 | Cho Esther | SVP, GC | — | $123.7K |
| 4 | Seehra Jasbir | CEO, Dir | — | $113.4K |
| 5 | Lerner Lorena Raquel | CSO | — | $100.0K |
| 6 | Regnante Keith | CFO | — | $77.5K |
| 7 | BIENAIME JEAN JACQUES | Dir | $75.8K | — |
| 8 | Knowles Julius | Dir | — | $28.2K |
| 9 | Farzan Nima | Dir | — | $28.2K |
| 10 | Seth Alpna | Dir | — | $28.1K |
CHYUNG YUNG H. made no open-market trades at KROS in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-19 | 2025-02-18 | KROS | Keros Therapeutics, Inc. | CHYUNG YUNG H. | Chief Medical Off | A - Grant | $0.00 | +44.0K | 44.0K | New | $0 | |
| D | 2022-02-15 | 2022-02-14 | SRRK | Scholar Rock Holding Corp | CHYUNG YUNG H. | Chief Medical Off | A - Grant | $0.00 | +37.5K | 258.5K | +17% | $0 |
| 2022-01-19 | 2022-01-18 | SRRK | Scholar Rock Holding Corp | CHYUNG YUNG H. | Chief Medical Off | F - Tax | $19.46 | -1,421 | 221.0K | -0.6% | -$27.7K |
Purchase Sale Sale after option exercise All abbreviations